Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Extended report

Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis

Authors

Jenny Augustsson PubMed articles Google scholar articles
Staffan Eksborg PubMed articles Google scholar articles
Sofia Ernestam PubMed articles Google scholar articles
Eleanor Gullström PubMed articles Google scholar articles
Ronald van Vollenhoven PubMed articles Google scholar articles

Jenny Augustsson, Karolinska Pharmacy, Karolinska University Hospital Solna, 171 76 Stockholm, Sweden; jenny.augustsson{at}apoteket.se

Citation

Augustsson J, Eksborg S, Ernestam S, et al

Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases 2007;66:1462-1466.

Publication history

Accepted April 30, 2007
First published May 14, 2007.

Online issue publication

October 25, 2017

Copyright information

2007 BMJ Publishing Group Ltd and European League Against Rheumatism